Articles tagged with Immune Response
Researchers discovered that immune cells count their neighbors before activating to avoid overreactions. This new understanding could lead to improved cancer immunotherapies and treatments for autoimmune diseases.
A team at Columbia University's Mailman School of Public Health has developed a new method that accurately predicts human disease outcomes based on gene expression in individuals infected with Ebola. The model uses machine learning and was tested on a data set collected from Ebola patients in western Africa, confirming its accuracy.
Researchers have developed a novel technique to isolate individual gut cells from mice infected with intestinal parasites, enabling the study of the immune response to these infections. The technique may help scientists understand how adult parasites evade the immune system and develop ways to boost the immune response.
Researchers discovered that shortly after a stroke, macrophages from the blood attack dead and adjacent healthy brain tissue. This process was hindered by inactivating the Cxcr4 gene, which acts like an antenna for inflammatory processes in the brain.
Researchers have discovered high levels of PFAS chemicals in the blood of Cape Fear River striped bass, which are associated with altered immune and liver functions. The study found elevated concentrations of PFOS and Nafion byproduct 2, particularly in smaller or younger fish, highlighting the unique properties of these chemicals.
A study found that childhood vaccine responses are shaped by geography, age, and anemia status. Children with anemia showed weaker immune responses to malaria vaccines in Tanzania and Mozambique.
Researchers charted immune system development in sub-Saharan African children to improve vaccine efficacy. Their findings suggest that a child's age, location, and health status influence their immune response to vaccines.
A new study found that immune system composition changes significantly during early childhood, with anaemia potentially reducing vaccine responses in low-income countries. The research, published in Science Translational Medicine, analyzed blood samples from children in Mozambique and Tanzania.
A vaccine clinical trial for pregnant women with malaria has shown promising results, demonstrating safety and an appropriate immune response. The PRIMVAC vaccine was found to be well-tolerated and induced antibodies capable of recognizing the Plasmodium falciparum parasite.
New research shows that feeding bluebirds can significantly impact parasitic nest flies and improve nestling survival. The study found that supplementing birds with food reduces the parasite load and improves antibody levels, which help kill the parasites. The timing of feeding is also crucial, with early feeding benefiting young birds...
Researchers at Massachusetts General Hospital developed mathematical models to predict how tumors may respond to immunotherapy and how adding other anti-cancer drugs could lead to improved treatment. The models suggest that normalization of the tumor microenvironment, including blood supply, could improve treatment efficacy.
A severely infected patient revealed a rare genetic variation in immune deficiency, linked to CMV control. Researchers sequenced the man's genes and found a mutation in NOS2, a critical component of macrophages that kill microbes.
A new method to produce cheaper, longer-lasting vaccines has been developed using a protein called polyhedrin. Researchers found that PH(1-110) particles stored as dry powder can still generate antibodies after up to twelve months of storage.
Researchers found that B-cell markers were associated with improved overall survival in patients with advanced melanoma and soft-tissue sarcomas. B cells located within specialized immune-cell clusters (TLS) were predictive of response to checkpoint blockade, suggesting a dynamic interaction between immune components.
Researchers found BPA exposure triggers an immune response that passes down through generations, leading to increased risk of allergic asthma. The study suggests that even after removal from the environment, descendants may still inherit changes in DNA expression that cause aberrant immune system activation.
Scientists from the German Cancer Research Center have identified a receptor on murine immune cells that activates a protective mechanism preventing unwanted immune responses against the body's own tissues. Dectin-1 binds to annexins on dying cells, suppressing the immune response and preventing autoimmune reactions.
A brief disruption to a molecular pathway in mice before birth compromises adult immunity to rotavirus, preventing antibody responses and interfering with gut cells that support antibody production.
A host sensor called AhR helps the immune system respond to bacterial infections by detecting and adapting to quorum sensing signals. This allows for tailored defense mechanisms against highly resistant pathogens like Pseudomonas aeruginosa.
A recent study found that probiotics and prebiotics have distinct effects on the immune systems of male and female piglets, contradicting previous assumptions. This research highlights the importance of considering sex in nutritional trials and may lead to personalized treatment approaches for infants.
KAUST scientists have identified MAP4K4 as a key player in plant immunity, essential for proper responses to environmental pathogens. The discovery reveals targets in a molecular pathway that could be manipulated by crop breeders to make plants more resistant.
Researchers have developed a new way to measure white blood cell function, providing more accurate prognostic information for patients with sepsis. The technology assesses activation state and function of white blood cells from small blood samples, allowing for earlier diagnosis and treatment.
A newly developed experimental vaccine has demonstrated over 80% effectiveness in protecting mice from succumbing to Staphylococcus aureus infection. The vaccine targets specific proteins found on the bacteria and has shown promise in preventing biofilm formation, a major cause of hospital-acquired infections.
Researchers at Georgia State University have identified the critical protein Z-DNA binding protein 1 (ZBP1), which plays a significant role in triggering an immune response to viral infections. The study found that ZBP1 is essential for restricting West Nile and Zika virus replication, preventing severe disease outcomes.
The study developed a new method combining mass spectrometry technology and machine learning to identify HLA-II binding motifs, leading to improved prediction of immunogenic peptides. This advancement will refine personalized immunotherapy for cancer treatment.
Researchers at the Weizmann Institute of Science and Germany's University of Cologne have identified two antibodies produced by vaccinated individuals that provide long-term immunity against Ebola. These antibodies, which target specific sites on the viral glycoprotein, demonstrate effective protection against the virus.
Scientists at the University of Dundee have mapped how T lymphocytes control expression of over 9,000 proteins in response to infections and tumours. The study reveals critical discoveries on how immune-suppressive drugs work and how oxygen and nutrient environments shape immune responses.
The US FDA has approved a new smallpox vaccine called JYNNEOS, which is non-replicating and can be used to protect against both smallpox and monkeypox diseases. The vaccine developed by Bavarian Nordic was shown to have a superior immune response compared to the existing ACAM2000 vaccine.
The NIH has awarded contracts to establish three new centers for immunology research to accelerate progress in TB vaccine development. The program aims to develop a comprehensive understanding of the immune responses required to prevent TB infection and disease.
A recent study by Nicolas Cermakian and Nathalie Labrecque found that the biological clock influences immune response efficacy in CD8 T cells. The study discovered that the strength of the immune response varied according to the time of day, with mice showing a stronger response to vaccination at certain times.
A new study on sheep aging found that declining immune function accelerates parasite infections, leading to early mortality. The research, which tracked over 800 individual animals, discovered a link between antibody availability and mortality risk.
A study found a germline mutation in the CD137 gene to be associated with childhood lymphoma, highlighting its key role in immune surveillance against EBV infection. The research aims to develop targeted therapeutics to stop this disease process.
The RV144 vaccine has shown promising results with a new study indicating it may provide protection against multiple strains of HIV. Researchers discovered that the vaccine elicited stronger immune responses, particularly in men, and was well-tolerated, suggesting potential long-term efficacy.
The study reveals that ectosomes, tiny vesicles containing key immune messages, can be intercepted and deciphered using super resolution microscopy. This breakthrough understanding of cellular communication has significant implications for developing therapies that shape the immune response to specific diseases.
A study by Emory Vaccine Center and CDC found immunity against mumps virus insufficient in a fraction of college-aged people who received MMR as children. The results highlight the need for better understanding of immune response to mumps and vaccines.
A team of biologists has shed new light on a crucial aspect of the plant immune response, revealing how plant resistance proteins trigger localized cell death. By understanding this mechanism, scientists may develop strategies for engineering disease-resistant crops.
A new chlamydia vaccine has shown promising early signs of effectiveness in a phase 1 clinical trial, provoking an immune response in all participants. The vaccine, CTH522, demonstrated improved performance with added liposomes, producing higher antibody levels and a more consistent cell-mediated immune response.
A new study suggests that nitazoxanide, an FDA-approved anti-parasitic drug, could potentially treat Ebola by enhancing the immune system's ability to detect the virus. The drug inhibited Ebola replication and worked by broadly amplifying the interferon pathway and cellular viral sensors.
A PSU biologist is investigating the link between a Western diet high in fat and sugar and its effects on the immune system, with a focus on chronic inflammation and sepsis severity. The researcher aims to identify molecular mechanisms behind this relationship and explore potential dietary interventions.
A study found that women's immune response to the flu vaccine is stronger than men's, but declines with age, especially in women. Researchers discovered that estrogen levels boost female immunity, while testosterone has a weaker effect on male responses.
A new study published in The Plant Cell found that plant immune systems vary between species, contradicting previous assumptions based on Arabidopsis thaliana research. Researchers used CRISPR/Cas9 genome editing techniques to investigate the tobacco plant Nicotiana benthamiana's immune response.
The approach demonstrated in mice enhances healing by reprogramming aggressive immune cells to work for the body, reducing inflammation and promoting regeneration. This technology could lead to new therapeutic strategies for patients with spinal cord injury and inflammatory diseases.
A recent study published in Proceedings of the National Academy of Sciences shows that mosquitoes employ a multi-stage immune response to combat malaria parasites, involving a complement-like pathway and phenoloxidases. This understanding could lead to opportunities to eliminate malaria parasites in the mosquito, reducing human cases.
Female bed bugs exhibit induced antibacterial humoral immune responses when fed regularly, with a 22% increase in longevity compared to unpredictable feeding schedules. Anticipation of mating-associated infection through feeding cues may influence reproductive immune anticipation.
Researchers at St. Jude Children's Research Hospital found that children with acute lymphoblastic leukemia mount a robust immune response to their cancer. The study suggests that the immune system may be able to effectively target pediatric ALL, potentially leading to new immunotherapy treatments.
Researchers studying CD73, an enzyme suppressing the natural immune response, hope to block its production to help treat aggressive head and neck cancers. High levels of CD73 are associated with poor prognosis in these cancers.
Researchers developed a novel mouse model of intestinal parasite infection that mimics human disease, offering protection against Cryptosporidium infection. The model uses a naturally occurring species of mouse Cryptosporidium and demonstrates the importance of T cells and interferon-gamma in immune response.
Dr. Julie Marchesan, a rising young researcher, is the recipient of the $10,000 AADR Anne D. Haffajee Fellowship to support women in oral biology research. The fellowship aims to increase female representation in science and academia.
Researchers identified Roseburia intestinalis as a gut bacterium triggering antiphospholipid antibodies in patients with antiphospholipid syndrome. The study suggests that eliminating this bacterium may help decrease antibody levels and open doors for future treatment options.
Scientists studying Leishmania parasites found that they can mate to produce hybrid offspring carrying genetic material from multiple strains, suggesting a true sexual reproductive cycle. This discovery could lead to improved treatment for deadly Leishmaniasis infections.
A new study by immunologists at the Babraham Institute has shown that fecal transplants from young mice can replenish and boost the gut microbiome of older mice, rejuvenating their immune system. The research suggests that targeting the gut microbiome could be a way to treat age-related symptoms and facilitate healthy aging.
A new method using flow cytometry has been developed to measure the immune response in islet transplant recipients. This standardized approach helps predict patient outcomes and could enable early intervention to prevent rejection.
A new study from Rockefeller University reveals that the gut is organized into compartments with different immune system functions in each segment. This discovery has potential to improve drugs for gastrointestinal disorders and inform the development of oral vaccines.
New research at the University of Sheffield reveals that dead cells can disrupt the normal function of immune cells, called macrophages, which are crucial for responding to wounds and patrolling for infection. The study's findings could lead to new therapies to manipulate white blood cells and accelerate healing processes.
Researchers found that Ebola survivors developed high levels of neutralizing antibodies months after recovery, which could inform the design of antiviral therapies and vaccines. The study's findings have implications for understanding immune protection after vaccination and developing effective treatments.
Scientists at La Jolla Institute for Immunology developed a new HIV vaccine delivery strategy that enhances the protective immune response by slowly releasing vaccine doses. This approach, called escalating dose strategy, leads to stronger and more neutralizing antibodies against the virus.
Researchers at Swansea University's Medical School have found that immune cells can re-programme their metabolic pathways to provide energy and building blocks when challenged. This discovery suggests that manipulating metabolism could lead to new therapies for infectious diseases and cancer.
Researchers at Northwestern University have designed spherical nucleic acids (SNAs) that stimulate powerful anti-cancer immune responses, completely eliminating tumors in 30% of animals and improving overall survival. The study's findings highlight the importance of chemical structure and three-dimensional presentation in vaccine design.
Researchers have identified a key enzyme that helps cancer cells survive by eliminating junk RNA. Targeting this enzyme, ADAR, may lead to breakthroughs in treating various types of cancer.
Researchers found that combining tumor-selective angiotensin blockers with immune checkpoint blockers significantly improves breast cancer treatment in mouse models. The combination treatment normalizes the tumor microenvironment, inducing changes in gene expression and activating immunosupportive pathways.
Researchers at the La Jolla Institute for Immunology discovered that genetic deletion of TET2 and TET3 in mouse B cells impairs the generation of functional IgG antibodies, highlighting the critical role of epigenetic control in healthy immune cell function.